Segantii Capital Management LTD Zai Lab LTD Transaction History

Segantii Capital Management LTD

$807 Million
Q1 2024

A detailed history of Segantii Capital Management LTD transactions in Zai Lab LTD stock. As of the latest transaction made, Segantii Capital Management LTD holds 1,555,931 shares of ZLAB stock, worth $54.6 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares

1,555,931

Previous 1,687,569 7.8%

Holding current value

$54.6 Million

Previous $46.1 Million 45.96%

% of portfolio

3.09%

Previous 4.5%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$15.95 - $26.8 $2.1 Million - $3.53 Million	-131,638 Reduced 7.8%	1,555,931 $24.9 Million
Q4 2023 Feb 06, 2024	SELL	$22.97 - $30.58 $2.33 Million - $3.1 Million	-101,430 Reduced 5.67%	1,687,569 $46.1 Million
Q3 2023 Nov 06, 2023	SELL	$22.72 - $31.49 $147,225 - $204,055	-6,480 Reduced 0.36%	1,788,999 $43.5 Million
Q2 2023 Aug 01, 2023	SELL	$25.3 - $39.67 $12.2 Million - $19.2 Million	-482,796 Reduced 21.19%	1,795,479 $49.8 Million
Q1 2023 May 04, 2023	SELL	$30.21 - $48.1 $4.51 Million - $7.17 Million	-149,135 Reduced 6.14%	2,278,275 $75.8 Million
Q4 2022 Jan 30, 2023	BUY	$22.28 - $38.71 $222,800 - $387,100	10,000 Added 0.41%	2,427,410 $74.5 Million
Q3 2022 Nov 08, 2022	BUY	$34.2 - $51.69 $6.02 Million - $9.1 Million	176,136 Added 7.86%	2,417,410 $82.7 Million
Q2 2022 Aug 03, 2022	SELL	$23.14 - $49.68 $254,540 - $546,480	-11,000 Reduced 0.49%	2,241,274 $77.7 Million
Q1 2022 Apr 26, 2022	BUY	$27.77 - $64.4 $23.9 Million - $55.3 Million	859,274 Added 61.69%	2,252,274 $99.1 Million
Q4 2021 Jan 21, 2022	BUY	$54.9 - $105.21 $37.6 Million - $72.1 Million	685,003 Added 96.75%	1,393,000 $87.6 Million
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $34.4 Million - $58.4 Million	327,338 Added 85.99%	707,997 $74.6 Million
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $19.8 Million - $28.6 Million	158,617 Added 71.44%	380,659 $67.4 Million
Q1 2021 May 11, 2021	SELL	$126.27 - $191.71 $3.26 Million - $4.96 Million	-25,851 Reduced 10.43%	222,042 $29.6 Million
Q4 2020 Jan 27, 2021	SELL	$81.94 - $135.34 $49.2 Million - $81.3 Million	-600,786 Reduced 70.79%	247,893 $33.6 Million
Q3 2020 Nov 10, 2020	SELL	$73.3 - $89.48 $8.38 Million - $10.2 Million	-114,319 Reduced 11.87%	848,679 $70.6 Million
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $41.7 Million - $70.5 Million	-854,167 Reduced 47.01%	962,998 $79.1 Million
Q1 2020 May 08, 2020	SELL	$39.1 - $62.9 $60.6 Million - $97.5 Million	-1,550,135 Reduced 46.03%	1,817,165 $93.5 Million
Q4 2019 Jan 30, 2020	BUY	$29.79 - $43.06 $1.11 Million - $1.61 Million	37,300 Added 1.12%	3,367,300 $140 Million
Q3 2019 Oct 24, 2019	BUY	$30.47 - $37.65 $1.25 Million - $1.55 Million	41,112 Added 1.25%	3,330,000 $108 Million
Q2 2019 Jul 24, 2019	BUY	$25.73 - $35.79 $22.8 Million - $31.7 Million	885,888 Added 36.87%	3,288,888 $115 Million
Q1 2019 Apr 04, 2019	BUY	$21.71 - $31.54 $65,130 - $94,620	3,000 Added 0.13%	2,403,000 $70.9 Million
Q4 2018 Feb 05, 2019	BUY	$14.95 - $24.72 $17,984 - $29,738	1,203 Added 0.05%	2,400,000 $55.7 Million
Q3 2018 Oct 24, 2018	BUY	$17.8 - $25.35 $33.2 Million - $47.3 Million	1,864,352 Added 348.84%	2,398,797 $46.7 Million
Q2 2018 Aug 02, 2018	BUY	$18.0 - $25.01 $2.69 Million - $3.74 Million	149,445 Added 38.82%	534,445 $12.4 Million
Q1 2018 Apr 26, 2018	BUY	$20.05 - $26.96 $44,731 - $60,147	2,231 Added 0.58%	385,000 $8.22 Million
Q4 2017 Feb 08, 2018	BUY	$21.23 - $34.09 $3.31 Million - $5.32 Million	155,912 Added 68.73%	382,769 $8.13 Million
Q3 2017 Nov 03, 2017	BUY	$27.0 - $31.11 $6.13 Million - $7.06 Million	226,857	226,857 $6.13 Million

Others Institutions Holding ZLAB

# of Institutions

146

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.44B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.

Account

Segantii Capital Management LTD Zai Lab LTD Transaction History